Drepanocitosis en el niño

Bardakdjian-Michau, 2009, Neonatal screening for sickle cell disease in France, J Clin Pathol, 62, 31, 10.1136/jcp.2008.058867 Roberts, 2007, Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe, Haematologica, 92, 865, 10.3324/haematol.11474 De Franceschi, 2009, Pathophysiology and target pathways for novel therapies, 311 Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic mice but not in normal mice, J Clin Invest, 106, 411, 10.1172/JCI9225 Cartron, 2008, Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea, Transfus Clin Biol, 15, 39, 10.1016/j.tracli.2008.05.001 Morris, 2008, Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in haemolytic disorders, Curr Mol Med, 8, 620, 10.2174/156652408786241447 Lionnet, 2012, Hemoglobin sickle cell disease complications: a clinical study of 179 cases, Haematologica, 97, 1136, 10.3324/haematol.2011.055202 Sears, 1994, Sickle cell trait, 381 Vichinsky, 1998, Newborn screening for sickle cell disease: effect on mortality, Pediatrics, 81, 749, 10.1542/peds.81.6.749 Telfer, 2007, Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London, Haematologica, 92, 905, 10.3324/haematol.10937 Platt, 1984, Influence of sickle hemoglobinopathies on growth and development, N Engl J Med, 311, 7, 10.1056/NEJM198407053110102 Chapelon, 2009, Osteopenia and vitamin D deficiency in children with sickle cell disease, Eur J Haematol, 83, 572, 10.1111/j.1600-0609.2009.01333.x Gill, 1995, Clinical events in the first decade in a cohort of infants with sickle cell disease, Blood, 86, 776, 10.1182/blood.V86.2.776.bloodjournal862776 Platt, 1991, Pain in sickle cell disease. Rates and risk factors, N Engl J Med, 325, 11, 10.1056/NEJM199107043250103 Serjeant, 2001, The painful crisis, 281 Haute Autorité de Santé. Prise en charge de la drépanocytose chez l’enfant et l’adolescent. 2005. www.has-sante.fr/portail/display.jsp?id=c_272479. Bégué, 2003, Infections chez l’enfant drépanocytaire, 105 Almeida, 2003, Bone involvement in sickle cell disease, Br J Haematol, 120, 737 De Montalembert, 1993, Epidemiological and clinical study of sickle cell disease. French Guiana and Algeria, Eur J Haematol, 51, 136, 10.1111/j.1600-0609.1993.tb00613.x Quinet, 2003, Les complications ostéoarticulaires de la drépanocytose chez l’enfant, 161 Gendrel, 1991, Protection against Plasmodium falciparum infection in children with hemoglobin S, Pediatr Infect Dis J, 10, 620, 10.1097/00006454-199108000-00013 Brousse, 2012, Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients, Br J Haematol, 156, 643, 10.1111/j.1365-2141.2011.08999.x Smith-Whitley, 2004, Epidemiology of human parvovirus B19 in children with sickle cell disease, Blood, 103, 422, 10.1182/blood-2003-01-0069 Ohene-Frempong, 1998, Cerebrovascular accidents in sickle cell disease: rates and risk factors, Blood, 91, 288 Vichinsky, 2000, Causes and outcomes of the acute chest syndrome in sickle cell disease, N Engl J Med, 342, 1855, 10.1056/NEJM200006223422502 Rees, 2010, Sickle cell disease, Lancet, 376, 2018, 10.1016/S0140-6736(10)61029-X Quinn, 2010, Improved survival of children and adolescents with sickle cell disease, Blood, 115, 3447, 10.1182/blood-2009-07-233700 Bernaudin, 2011, Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort, Blood, 117, 1130, 10.1182/blood-2010-06-293514 De Montalembert, 2011, European Network for Rare and Congenital Anaemias. ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children, Am J Hematol, 86, 72, 10.1002/ajh.21865 Howard, 2010, Moving young people with sickle cell disease from paediatric to adult services, Br J Hosp Med, 71, 310, 10.12968/hmed.2010.71.6.48435 De Montalembert, 2012, Prise en charge des enfants drépanocytaires, Rev Prat Med Gen, 26, 9 Adams, 1992, The use of transcranial ultrasonography to predict stroke in sickle cell disease, N Engl J Med, 326, 605, 10.1056/NEJM199202273260905 Adams, 1998, Prevention of a first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography, N Engl J Med, 339, 5, 10.1056/NEJM199807023390102 Bernaudin, 2007, Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease, Blood, 110, 2749, 10.1182/blood-2007-03-079665 Mirre, 2010, Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease, Eur J Haematol, 84, 259, 10.1111/j.1600-0609.2009.01379.x Ware, 2012, SWiTCH Investigators. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH), Blood, 119, 3925, 10.1182/blood-2011-11-392340 de Montalembert, 2012, To SWiTCH or not to SWiTCH?, Blood, 119, 3870, 10.1182/blood-2012-02-410951 Charache, 1995, and the investigators of the Multicenter Study of Hydroxyurea in sickle cell anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia, N Engl J Med, 322, 1317, 10.1056/NEJM199505183322001 Strouse, 2008, Hydroxurea for sickle cell disease: a systematic review for efficacy and toxicity in children, Pediatrics, 122, 1332, 10.1542/peds.2008-0441 de Montalembert, 2006, French Study Group on Sickle Cell Disease. Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes, Haematologica, 91, 125 Alexandre, 1997, Efficiency of prenatal counselling for sickle cell disease in Guadeloupe, Genet Couns, 8, 25